Immune regulation by CD8

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

33 citing papers in PubMed.

1. Advances in Targeted and Immunotherapy for High-Risk Cutaneous Malignancies.Oncology research · 2026
   Review
2. Molecular roles of microRNA-21 and exosomal miR-21 in gastrointestinal cancers: diagnostic, therapeutic, and drug resistance insights.Frontiers in molecular biosciences · 2025
   Review
3. Recent advances in regulatory immune cells: exploring the world beyond Tregs.Frontiers in immunology · 2025
   Review
4. Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC).Cells · 2024
   Review
5. The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review.Cancers · 2024
   Review
6. Roles of exosomes in immunotherapy for solid cancers.Cell death & disease · 2024
   Review
7. Revolutionizing cancer treatment: the emerging potential and potential challenges ofTheranostics · 2024
   Review
8. The future of cancer immunotherapy: DNA vaccines leading the way.Medical oncology (Northwood, London, England) · 2023
   Review
9. Circulating CD4Medicina (Kaunas, Lithuania) · 2023
   Article
10. Understanding the squamous cell carcinoma immune microenvironment.Frontiers in immunology · 2023
    Review
11. Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
12. Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.Cancers · 2022
    Review
13. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8Cancers · 2022
    Article
14. Recent highlights in the immunomodulatory aspects of Treg cell-derived extracellular vesicles: special emphasis on autoimmune diseases and transplantation.Cell & bioscience · 2022
    Review
15. Impact of Early ARV Initiation on Relative Proportions of Effector and Regulatory CD8 T Cell in Mesenteric Lymph Nodes and Peripheral Blood During Acute SIV Infection of Rhesus Macaques.Journal of virology · 2022
    Article
16. FoxP3Frontiers in immunology · 2022
    Article
17. Simultaneous disruption of circulating miR-21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC).Journal of clinical laboratory analysis · 2022
    Article
18. Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy.Frontiers in immunology · 2022
    Review
19. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer.Cellular oncology (Dordrecht, Netherlands) · 2021
    Article
20. Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression.Biomedicines · 2021
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as